BPH ann. re:Cortical Dynamics
http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=00979202
because of GBA's holding in BPH
they will hold 7million shares in Cortical Dynamics
when they spin it off from BPH
http://biopharmica.com.au/documents/GBA-IPOintentionforBioPharmicaLtd-20070614.pdf
"Market
The depth of anaesthesia market is predicted to be worth
US$750 million by 2008. There are eight products in the
market and two companies whose focus is purely depth of anaesthesia monitoring. The benchmark monitor at present
is BIS (the Bispectra Index at Aspect Medical Systems Inc).
It has been shown in extensive clinical trials that improved
monitoring of the depth of anaesthesia reduces recovery
times, the costs of anaesthesia and the incidence of
postoperative recall."
Long-term there is a potentially huge growth market
as the population ages
"This brain activity monitor also has potential
in neuro-diagnostic applications, including the
detection of the early onset of neurodegenerative
diseases such as Alzheimer’s and Parkinson’s"
- Forums
- ASX - By Stock
- GBA
- bph/cortical dynamics
bph/cortical dynamics
Featured News
Add GBA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online